Incoming Non-Executive Director, Ms Sue MacLeman, commented:“I...

Incoming Non-Executive Director, Ms Sue MacLeman, commented:

“I am delighted to join the board of Rhythm having followed the company since its inception. I have been interested in improving public health for my whole career and have keenly followed the advancements and milestones achieved by Rhythm in recent times.

“The Company has the potential to transform the way colorectal cancer is detected and potentially on an international scale. I am looking forward to working with the team as the Company moves to commercialisation and realise the potential for this Australian developed technology. That, in addition to developing other simple, but transformative diagnostics products is something I am excited to be a part of and I am looking forward to using my skills and expertise to assist Rhythm as they scale globally.”